Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020.
作者信息
Shimabukuro Tom
机构信息
CDC COVID-19 Response Team, Atlanta, Georgia, USA.
Food and Drug Administration, Washington, DC, USA.
出版信息
Am J Transplant. 2021 Mar;21(3):1332-1337. doi: 10.1111/ajt.16516.
Abstract
摘要
相似文献
1
Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020.2020年12月14日至23日美国接种首剂辉瑞-生物科技公司新冠病毒疫苗后发生的过敏反应，包括过敏反应。
Am J Transplant. 2021 Mar;21(3):1332-1337. doi: 10.1111/ajt.16516.
2
Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.2020年12月21日至2021年1月10日美国接种第一剂莫德纳新冠疫苗后的过敏反应，包括过敏反应
Am J Transplant. 2021 Mar;21(3):1326-1331. doi: 10.1111/ajt.16517.
3
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
4
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗第一剂后包括过敏反应在内的过敏反应。
JAMA. 2021 Feb 23;325(8):780-781. doi: 10.1001/jama.2021.0600.
5
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.高过敏风险成年人接种辉瑞-BioNTech COVID-19 疫苗后的过敏反应发生率。
JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.
6
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.使用两步分级方案管理与 COVID-19 疫苗相关的疑似过敏反应和第二剂接种。
Allergy Asthma Proc. 2021 Nov 1;42(6):515-521. doi: 10.2500/aap.2021.42.210075.
7
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
8
Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.以色列接种辉瑞-BioNTech BNTT162B2 疫苗后过敏性反应报告。
J Allergy Clin Immunol Pract. 2022 Nov;10(11):2969-2976. doi: 10.1016/j.jaip.2022.07.012. Epub 2022 Jul 22.
9
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间，在接种 Moderna COVID-19 疫苗第一针后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
10
Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.接种辉瑞-生物科技公司首剂 COVID-19 mRNA 疫苗后出现双相过敏反应。
J Med Virol. 2021 Oct;93(10):6027-6029. doi: 10.1002/jmv.27109. Epub 2021 Jun 6.
引用本文的文献
1
Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress.推进用于传染病的信使核糖核酸疫苗：关键组成部分、创新与临床进展
Essays Biochem. 2025 May 1;69(2):EBC20253009. doi: 10.1042/EBC20253009.
2
Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.在超免疫猪模型中，Comirnaty诱导的心肺窘迫及补体介导的类过敏反应的其他症状：抗聚乙二醇抗体的因果作用
Vaccine X. 2024 May 23;19:100497. doi: 10.1016/j.jvacx.2024.100497. eCollection 2024 Aug.
3
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
4
DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond.用于疫情防范的DNA疫苗：新冠病毒及其他。
Vaccines (Basel). 2023 May 23;11(6):1016. doi: 10.3390/vaccines11061016.
5
Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review.新型冠状病毒肺炎、血脂异常和糖尿病中药物反应的性别差异：一项叙述性综述
Pharmaceuticals (Basel). 2023 Jun 7;16(6):853. doi: 10.3390/ph16060853.
6
The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management.机器学习在 COVID-19 大流行期间和长新冠管理中的卫生政策中的作用。
Front Public Health. 2023 Apr 11;11:1140353. doi: 10.3389/fpubh.2023.1140353. eCollection 2023.
7
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort.与BNT162b2、mRNA-1273或JNJ-78436735 SARS-CoV-2疫苗相关的不良反应、认知和态度：基于人群的队列研究
NPJ Vaccines. 2023 Apr 24;8(1):61. doi: 10.1038/s41541-023-00657-3.
8
A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme.异源新冠疫苗接种方案后休止期脱发和普秃的病例系列及文献综述
Vaccines (Basel). 2023 Feb 15;11(2):444. doi: 10.3390/vaccines11020444.
9
Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review.接种第二剂 BNT162b2 mRNA COVID-19 疫苗后出现嗜酸性粒细胞性结肠炎：病例报告并文献复习。
Intern Med. 2023 Mar 15;62(6):865-869. doi: 10.2169/internalmedicine.0518-22. Epub 2022 Dec 28.
10
Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.mRNA COVID-19 疫苗首剂即时反应的临床表型：一项多中心潜在类别分析。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):458-465.e1. doi: 10.1016/j.jaip.2022.08.048. Epub 2022 Sep 13.
本文引用的文献
1
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会关于使用辉瑞-BioNTech COVID-19 疫苗的临时建议-美国，2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924. doi: 10.15585/mmwr.mm6950e2.
2
The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.免疫实践咨询委员会关于分配 COVID-19 疫苗初始供应的临时建议-美国，2020 年。
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859. doi: 10.15585/mmwr.mm6949e1.
3
Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.与 COVID-19 相关的超额死亡人数，按年龄、种族和族裔划分 - 美国，2020 年 1 月 26 日至 10 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527. doi: 10.15585/mmwr.mm6942e2.
4
Vaccine-associated hypersensitivity.疫苗相关过敏反应。
J Allergy Clin Immunol. 2018 Feb;141(2):463-472. doi: 10.1016/j.jaci.2017.12.971.
5
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).疫苗不良事件报告系统（VAERS）中的安全性监测。
Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22.
6
Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.接种单价 2009 年甲型 H1N1 流感疫苗后的即刻超敏反应：向 VAERS 的报告。
Vaccine. 2013 Dec 9;31(51):6107-12. doi: 10.1016/j.vaccine.2013.09.066. Epub 2013 Oct 8.
7
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.过敏反应：免疫接种安全性数据的病例定义及数据收集、分析与呈现指南
Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12.
8
The reporting sensitivities of two passive surveillance systems for vaccine adverse events.两种疫苗不良事件被动监测系统的报告敏感性。
Am J Public Health. 1995 Dec;85(12):1706-9. doi: 10.2105/ajph.85.12.1706.
Zotero 插件